Retrophin (RTRX) Jumps: Stock Adds 13.5% in Session - Tale of the Tape

Retrophin, Inc. RTRX was a big mover last session with its shares rising nearly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading way above the past one month's volatile price range of $10.99 to $14.35.
 
This biopharmaceutical company has seen one negative estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same time frame. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday's rally can last.

Retrophin currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the biomedical industry may consider better-ranked stocks like Myriad Genetics Inc. MYGN, Gilead Sciences Inc. GILD and Illumina Inc. ILMN. All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
RETROPHIN INC RTRX: Get Free Report
 
MYRIAD GENETICS MYGN: Free Stock Analysis Report
 
GILEAD SCIENCES GILD: Free Stock Analysis Report
 
ILLUMINA INC ILMN: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!